Company Description
Blue Owl Capital Inc. operates as an alternative asset manager in the United States.
It offers permanent capital base solutions that enables it to offer holistic framework of capital solutions to middle market companies, large alternative asset managers, and corporate real estate owners and tenants.
The company also provides private financing solutions, such as direct lending products comprising diversified, technology, first lien, and opportunistic lending to middle-market companies; alternative credit; investment grade credit; liquid credit; and other credit solutions.
In addition, the company offers GP strategic capital products, which offers capital solutions, including GP minority stakes, GP debt financing, and professional sports minority stakes; and real estate products that focuses on acquiring triple net lease real estate by investment grade or creditworthy tenants, as well as real estate debt finance through net lease and real estate credit.
It offers its solutions through permanent capital vehicles and long-dated private funds. Blue Owl Capital Inc. is headquartered in New York, New York.
| Country | United States |
| Founded | 2020 |
| Industry | Asset Management |
| Sector | Financials |
| Employees | 1,365 |
| CEO | Douglas Irving Ostrover |
Contact Details
Address: 399 Park Avenue, 37th Floor New York, New York 10022 United States | |
| Phone | 212 419 3000 |
| Website | blueowl.com |
Stock Details
| Ticker Symbol | OWL |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001823945 |
| CUSIP Number | 09581B103 |
| ISIN Number | US09581B1035 |
| Employer ID | 86-3906032 |
| SIC Code | 6282 |
Key Executives
| Name | Position |
|---|---|
| Marc S. Lipschultz | Co-Founder, Co-Chief Executive Officer and Director |
| Douglas Irving Ostrover | Co-Founder, Chairman and Co-Chief Executive Officer |
| Michael Douglass Rees | Co-Founder, Co-President and Director |
| Andrew Robert Polland | Chief Operating Officer |
| Ann Dai | MD and Head of Investor Relations |
| Lamar Cardinez | Principal |
| Michael Conley | Senior Managing Director |
| Michael Gabriel | Managing Director |
| Cara Griffiths | Managing Director |
| Kate Ivers | Managing Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 17, 2026 | DEF 14A | Other definitive proxy statements |
| Apr 17, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 6, 2026 | SCHEDULE 13G/A | Filing |
| Mar 26, 2026 | SCHEDULE 13G/A | Filing |
| Mar 2, 2026 | 144 | Filing |
| Mar 2, 2026 | 144 | Filing |
| Feb 19, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| Feb 19, 2026 | 10-K | Annual Report |
| Feb 6, 2026 | SCHEDULE 13G/A | Filing |
| Feb 5, 2026 | SCHEDULE 13G/A | Filing |